Gemcitabine 2 GM Injection
RxNorm 1719005
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1719005 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: gemcitabine 2 GM Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
Gemcitabine 2000 mg Injection
(Atom ID: 7702832)
Designated preferred name (PT):
Gemcitabine (as gemcitabine hydrochloride) 2 g powder for solution for injection vial
(Atom ID: 11436857)
Synonym (SY):
Gemcitabine (as gemcitamine HCl) 2 GM Injection
(Atom ID: 7707235)
Prescribable Name (PSN):
Gemcitabine 2 GM Injection
(Atom ID: 7706057)
Synonym (SY):
Gemcitabine 2 GM Injection
(Atom ID: 7706058)
Full form of descriptor (FN):
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)
(Atom ID: 11439978)
Patient Education
Gemcitabine Injection
Gemcitabine is used in combination with carboplatin to treat ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed) that returned at least 6 months after finishing a previous treatment. It also used in combination with paclitaxel (Abraxane, Taxol) to treat breast cancer that has not improved or that has worsened after treatment with other medications. Gemcitabine is used in combination with cisplatin to treat a type of lung cancer (non-small cell lung cancer; NSCLC) that has spread to other parts of the body and cannot be treated with surgery. Gemcitabine is also used to treat pancreatic cancer that has spread to other parts of the body and has not improved or worsened after treatment with another medication. Gemcitabine is in a class of medications called antimetabolites. It works by slowing or stopping the growth of cancer cells in your body.
[Learn More]
Cancer Chemotherapy
Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.
You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.
Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).
NIH: National Cancer Institute
[Learn More]
* Please review the disclaimer below.
